Articles tagged with 'TB' | University of Manchester

TaBriX is a new spin-out company from The University of Manchester (UoM) with the mission to create novel anti-virulence drugs to fight difficult-to-treat infections. TaBriX’s initial focus is on the treatment of drug-resistant TB.

Around 1 in 15 people affected by tuberculosis are likely get the treatable fungal infection aspergillosis according to new research by experts at The University of Manchester and Gulu Referral Hospital, Uganda.

Scientists at The University of Manchester have developed the first non-antibiotic drug to successfully treat tuberculosis in animals.

Researchers at The University of Manchester are developing a new drug against tuberculosis (TB), one of the oldest human infectious diseases, which is now threatening to reach epidemic proportions once more. TB poses a serious threat to all …